ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252 | -69.2% | 9,277 | -65.2% | 0.02% | -59.7% |
| Q2 2023 | $819 | +173.0% | 26,636 | +250.3% | 0.06% | +55.0% |
| Q4 2022 | $300 | -99.9% | 7,604 | +5.8% | 0.04% | +53.8% |
| Q3 2022 | $289,000 | -18.6% | 7,187 | -26.9% | 0.03% | -16.1% |
| Q3 2021 | $355,000 | -63.7% | 9,833 | -58.7% | 0.03% | -67.4% |
| Q2 2021 | $977,000 | +219.3% | 23,827 | +278.3% | 0.10% | +171.4% |
| Q2 2020 | $306,000 | – | 6,299 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |